Moreover, CMGCL could increase PD‐L1 expression on lung cancer cells by simultaneously mediating cancer starvation and cuproptosis, thus effectively sensitizing αPD‐L1 therapy against both primary and metastatic LLC tumors. This evidence concerns the gene CD274 and cancer.